Skip to main content
. 2018 May 26;10(2):64. doi: 10.3390/pharmaceutics10020064

Figure 1.

Figure 1

Powder X-ray diffraction (PXRD) patterns of benexate hydrochloride (BEX–HCl) (blue), sodium saccharinate (red), benexate-saccharinate (BEX–SAC) (purple), sodium cyclamate (yellow), and benexate-cyclamate (BEX–CYM) (green). The solid and dashed lines represent the experimental and simulated PXRD patterns, respectively.